(Q57668634)

1

0 references

author name string

Juan José Soler-Cataluña

2

0 references

Myriam Calle

3

0 references

Jesús Molina

4

0 references

Pere Almagro

5

0 references

José Antonio Quintano

6

0 references

Juan Antonio Riesco

7

0 references

Juan Antonio Trigueros

8

0 references

Pascual Piñera

9

0 references

Adolfo Simón

10

0 references

José Luis López-Campos

11

0 references

Julio Ancochea

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

13

0 references

publication date

July 2012

0 references

published in

Atención Primaria

0 references

volume

44

0 references

issue

7

0 references

page(s)

425-437

0 references

cites work

1 reference

12 December 2020

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

1 reference

12 December 2020

The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study

1 reference

12 December 2020

Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Clinical phenotypes of COPD: identification, definition and implications for guidelines

1 reference

12 December 2020

The clinical features of the overlap between COPD and asthma

1 reference

12 December 2020

Evaluation of withdrawal of maintenance tiotropium in COPD.

1 reference

12 December 2020

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

1 reference

12 December 2020

Physical activity in patients with COPD.

1 reference

12 December 2020

[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]

1 reference

12 December 2020

Cough and sputum production as risk factors for poor outcomes in patients with COPD.

1 reference

12 December 2020

Factors associated with bronchiectasis in patients with COPD.

1 reference

12 December 2020

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

1 reference

12 December 2020

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

1 reference

12 December 2020

Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease

1 reference

12 December 2020

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

12 December 2020

Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year

1 reference

12 December 2020

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations

1 reference

12 December 2020

The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study

1 reference

12 December 2020

Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients

1 reference

12 December 2020

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

1 reference

12 December 2020

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes

1 reference

12 December 2020

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

1 reference

12 December 2020

Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.

1 reference

12 December 2020

A new perspective on optimal care for patients with COPD.

1 reference

12 December 2020

Epidemiology and costs of chronic obstructive pulmonary disease.

1 reference

12 December 2020

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease

1 reference

12 December 2020

Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology

1 reference

12 December 2020

Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease

1 reference

12 December 2020

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

1 reference

12 December 2020

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

1 reference

12 December 2020

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

12 December 2020

Prophylactic antibiotic therapy for chronic bronchitis

1 reference

12 December 2020

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

1 reference

12 December 2020

Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study

1 reference

12 December 2020

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

1 reference

12 December 2020

Roflumilast with long-acting 2-agonists for COPD: influence of exacerbation history

1 reference

12 December 2020

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

1 reference

12 December 2020

[Usefulness of macrolides as anti-inflammatories in respiratory diseases]

1 reference

12 December 2020

The overlap syndrome of asthma and COPD: what are its features and how important is it?

1 reference

12 December 2020

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

1 reference

12 December 2020

Chronic mucus hypersecretion in COPD and death from pulmonary infection

1 reference

12 December 2020

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial

1 reference

12 December 2020

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

12 December 2020

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

1 reference

12 December 2020

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

1 reference

12 December 2020

Impact of changes in physical activity on health-related quality of life among patients with COPD.

1 reference

12 December 2020

[Treatment strategies in chronic obstructive pulmonary disease: a proposal for standardization]

1 reference

12 December 2020

Lung function impairment, COPD hospitalisations and subsequent mortality

1 reference

12 December 2020

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline

1 reference

12 December 2020

Targeted treatment in COPD: a multi-system approach for a multi-system disease

1 reference

12 December 2020

Hacia un nuevo enfoque en el tratamiento de la EPOC. La Guía Española de la EPOC (GESEPOC)

1 reference

12 December 2020

QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease

1 reference

12 December 2020

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations

1 reference

12 December 2020

Azithromycin for prevention of exacerbations of COPD.

1 reference

12 December 2020

Corticoides inhalados en la EPOC por fenotipo en lugar de por gravedad. Argumentos a favor

1 reference

12 December 2020

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.

1 reference

12 December 2020

[Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]

1 reference

12 December 2020

Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

12 December 2020

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice

1 reference

12 December 2020

Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.

1 reference

12 December 2020

[Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery]

1 reference

12 December 2020

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

1 reference

12 December 2020

Development and first validation of the COPD Assessment Test

1 reference

12 December 2020

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

1 reference

12 December 2020

Predictive accuracy of patient-reported exacerbation frequency in COPD.

1 reference

12 December 2020

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update

1 reference

12 December 2020

Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD.

1 reference

12 December 2020

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

1 reference

12 December 2020

[Individually-tailored treatment of chronic obstructive pulmonary disease: a proposed change]

1 reference

12 December 2020

Properties of the COPD assessment test in a cross-sectional European study

1 reference

12 December 2020

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol

1 reference

12 December 2020

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

1 reference

12 December 2020